Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
- 1 Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA
- 2 School of Computing, Informatics, and Decision Systems Engineering, Tempe, Arizona, USA
- 3 School of Industrial and Systems Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA
- 4 Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA
- 5 Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA
Abstract
Purpose: To examine possible association between heart irradiation and Overall Survival (OS) in lung SBRT patients and to compare observed associations with cardiac toxicity models previously derived in LA-NSCLC patient studies. Materials and Methods: 197 Patients treated with lung SBRT at Mayo Clinic Arizona were selected for this IRB - approved study. Multivariate Cox model with Akaike Information Criterion (AIC) was used to select patient specific covariates associated with OS. Heart dosimetry was represented by V D indices, which is a percentage of volume exposed to dose D or greater. Multivariate Cox model s with patient specific covariates and single V D index per model was used to find a range of doses which were predictive for OS. A digital subdivision of the heart was further used to determine the spatial distribution of doses which were predictive for OS. A coarse subdivision divided heart into 4 segments, while the fine subdivision divided heart into 64 segments. Knowledge constrained Fused Lasso operator was used to derive a more complete model which correlated heart dosimetry with OS. Results of statistical analysis were compared to predictions of a model of cardiac toxicity in LA-NSCLC patients. Results: Higher age (p < 0.001), higher stage (p < 0.001) and squamous cell histology (p = 0.001) were associated with reduced OS. Whole heart DVH analysis did not reveal associations between heart irradiation and reduced OS. Coarse subdivision of the heart into four segments revealed that the irradiation of two inferior segments of the heart with low doses was associated with reduced OS, V 2 Gy in the right-inferior segment (HR = 1.012/1%, p = 0.02), and V 1 Gy in the left-inferior segment (HR = 1.01/1%, p = 0.04). Maximum dose in the right-inferior segment of the heart was also associated with reduced OS (HR = 1.02/Gy, p = 0.02). Fine subdivision of the heart into 64 segments revealed that approximately 25% of heart volume in the inferior part of the heart (15/64 segments), when irradiated to doses in the 1 Gy - 5 Gy range, were predictive for reduced OS (HR = 1.01/1%, p = 0.01). A previously derived model of cardiac toxicity in LA-NSCLC patients did not predict a reduction of OS due to heart irradiation in lung SBRT patients, because of relatively low doses to the heart in most lung SBRT patients. Conclusions: Doses lower than 5 Gy in the inferior segments of the heart may be associated with reduced overall survival in patients treated for lung lesions with SBRT. Stage and histology of the disease, as well as patients’ age, were also associated with overall survival. Comparisons of cardiac toxicity patterns in LA-NSCLC patients and lung SBRT patients suggest different etiology of cardiac toxicity in the two groups.
- Lancellotti, P., Nkomo, V., Badano, L., Berglee, J., Bogaert, J., Davin, L., et al. (2013) Expert Consensus for Multi-Modality Imaging Evaluation of Cardiovascular Complications of Radiotherapy in Adults: A Report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Journal of the American Society of Echocardiography, 26, 1013. https://doi.org/10.1016/j.echo.2013.07.005
- Boda-Heggemann, J., Knopf, A., Simeonova-Chergou, A., Wertz, H., Stieler, F., Jahnke, A., et al. (2016) Deep Inspiration Breath Hold—Based Radiation Therapy: A Clinical Review. International Journal of Radiation Oncology*Biology*Physics, 94, 478-492. https://doi.org/10.1016/j.ijrobp.2015.11.049
- Chun, S.G., Hu, C., Choy, H., Komaki, R.U., Timmerman, R.D., Schild, S.E., et al. (2017) Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial. Journal of Clinical Oncology, 35, 56-62. https://doi.org/10.1200/JCO.2016.69.1378
- Eaton, B., Pugh, S., Bradley, J., Masters, G., Kavadi, V., Narayan, S., et al. (2016) Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617. Journal of the National Cancer Institute, 108, djw034. https://doi.org/10.1093/jnci/djw034
- Dess, R.T., Sun, Y., Matuszak, M.M., Sun, G., Soni, P.D., Bazzi, L., et al. (2017) Cardiac Events after Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Oncology, 35, 1395-1402. https://doi.org/10.1200/JCO.2016.71.6142
- Wang, K., Eblan, M.J., Deal, A.M., Lipner, M., Zagar, T.M., Wang, Y., et al. (2016) Cardiac Toxicity after Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy. Journal of Clinical Oncology, 35, 1387-1394. https://doi.org/10.1200/JCO.2016.70.0229
- Wang, K., Pearlstein, K.A., Patchett, N.D., Deal, A.M., Mavroidis, P., Jensen, B.C., et al. (2017) Heart Dosimetric Analysis of Three Types of Cardiac Toxicity in Patients Treated on Dose-Escalation Trials for Stage III Non-Small-Cell Lung Cancer. Radiotherapy and Oncology, 125, 293-300. https://doi.org/10.1016/j.radonc.2017.10.001
- Liu, X., Fatyga, M., Schild, S.E. and Li, J. (2020) Detecting Spatial Susceptibility to Cardiac Toxicity of Radiation Therapy for Lung Cancer. IISE Transactions on Healthcare Systems Engineering, 10, 243-250. https://doi.org/10.1080/24725579.2020.1795012